COVID-19 who have high risk of progression of the disease. Glenmark earlier received manufacturing and marketing approval from the Drugs Controller General of India (DCGI) for NONS as part of the accelerated approval process. “As a leading pharmaceutical player, it is important that we are an integral part of India’s fight against the COVID-19 pandemic.
We are happy to receive regulatory approval for Nitric Oxide Nasal Spray (FabiSpray®) and launch it in partnership with SaNOtize.
This reaffirms our commitment to providing yet another safe and effective antiviral treatment for COVID-19, and we are confident it will offer patients a much needed and timely therapy option,"Robert Crockart, Chief Commercial Officer, Glenmark Pharmaceuticals Ltd.
said. What is FabiSpray FabiSpray, Nitric Oxide Nasal Spray, is designed to kill the COVID-19 virus in the upper airways.